169 related articles for article (PubMed ID: 19584921)
1. L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network.
Jubault T; Monetta L; Strafella AP; Lafontaine AL; Monchi O
PLoS One; 2009 Jul; 4(7):e6154. PubMed ID: 19584921
[TBL] [Abstract][Full Text] [Related]
2. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
[TBL] [Abstract][Full Text] [Related]
3. Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.
Gul A; Yousaf J
Singapore Med J; 2019 Aug; 60(8):414-417. PubMed ID: 30246215
[TBL] [Abstract][Full Text] [Related]
4. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
5. Levodopa and the feedback process on set-shifting in Parkinson's disease.
Au WL; Zhou J; Palmes P; Sitoh YY; Tan LC; Rajapakse JC
Hum Brain Mapp; 2012 Jan; 33(1):27-39. PubMed ID: 21438075
[TBL] [Abstract][Full Text] [Related]
6. Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration.
Yang W; Liu B; Huang B; Huang R; Wang L; Zhang Y; Zhang X; Wu K
PLoS One; 2016; 11(9):e0161935. PubMed ID: 27611959
[TBL] [Abstract][Full Text] [Related]
7. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
8. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D
J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108
[TBL] [Abstract][Full Text] [Related]
9. Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
Kraft E; Loichinger W; Diepers M; Lule D; Schwarz J; Ludolph AC; Storch A
Parkinsonism Relat Disord; 2009 Sep; 15(8):558-63. PubMed ID: 19467909
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
12. l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.
Akram H; Wu C; Hyam J; Foltynie T; Limousin P; De Vita E; Yousry T; Jahanshahi M; Hariz M; Behrens T; Ashburner J; Zrinzo L
Mov Disord; 2017 Jun; 32(6):874-883. PubMed ID: 28597560
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic modulation of prospective memory in Parkinson's disease.
Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
Behav Neurol; 2008; 19(1-2):45-8. PubMed ID: 18413916
[TBL] [Abstract][Full Text] [Related]
14. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
15. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
[TBL] [Abstract][Full Text] [Related]
16. The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease.
Miller NS; Kwak Y; Bohnen NI; Müller ML; Dayalu P; Seidler RD
Behav Brain Res; 2013 Nov; 257():100-10. PubMed ID: 24076152
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
Cools R
Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
[TBL] [Abstract][Full Text] [Related]
18. Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study.
Maillet A; Krainik A; Debû B; Troprès I; Lagrange C; Thobois S; Pollak P; Pinto S
PLoS One; 2012; 7(10):e46541. PubMed ID: 23056337
[TBL] [Abstract][Full Text] [Related]
19. L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.
Kelly C; de Zubicaray G; Di Martino A; Copland DA; Reiss PT; Klein DF; Castellanos FX; Milham MP; McMahon K
J Neurosci; 2009 Jun; 29(22):7364-78. PubMed ID: 19494158
[TBL] [Abstract][Full Text] [Related]
20. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
